Type C is open to interpretation. Good v bad is difficult to say and is based on submission. FDA have had the submission for a month, enough to interpret and respond.
Type C could indicate submission is straight forward, updated phase 2 results, EMA one study would be considered too. Going after pressure and headache and hopefully to division of Neurology. NOT to opthomology.
Type C could indicate that a simple written reply and response (maybe to grant one study only!!).
My interpretation but basing off incomplete information that no one in the market will be privy to.
This is progress is the news. And in that respect it is good.
- Forums
- ASX - By Stock
- Ann: Invex Granted Type C Meeting with FDA
Type C is open to interpretation. Good v bad is difficult to say...
-
-
- There are more pages in this discussion • 129 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
6.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.885M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 7950 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24 | 0.066 |
1 | 155 | 0.060 |
1 | 100000 | 0.052 |
2 | 410000 | 0.051 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 7950 | 1 |
0.078 | 20000 | 1 |
0.081 | 888 | 1 |
0.083 | 4000 | 1 |
0.086 | 68122 | 1 |
Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online